ZacharyDaleGoodmanMD

Pathology • Falls Church, VA

Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Goodman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goodman's full profile

Already have an account?

Office
3300 Gallows Rd
Falls Church, VA 22042
Phone+1 301-802-1820

Fax+1 703-776-3100

Education & Training

Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1975 - 1980
Vanderbilt University School of MedicineClass of 1975

Certifications & Licensure

MD State Medical License 1979 - 2026
VA State Medical License 2010 - 2026
DC State Medical License 2010 - 2013
FL State Medical License 2010 - 2012
PA State Medical License 2010 - 2010
American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Severe acute liver disease in adults: Contemporary role of histopathology.
Andrew D Clouston, Annette S H Gouw, Dina Tiniakos, Pierre Bedossa, Elizabeth M Brunt
Histopathology. 2024-10-01
1 citations
Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma.
Gwyneth S T Soon, Francesco Callea, Alastair D Burt, Sam Cook, Luigi Terracciano
Human Pathology. 2024-07-01
4 citations
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease.
Zachary D Goodman
Clinics in Liver Disease. 2023-05-01

Journal Articles

An Exploratory Study Examining How Nano-Liquid Chromatography–Mass Spectrometry and Phosphoproteomics Can Differentiate Patients with Advanced Fibrosis and Higher Perc...
Zobair M Younossi, Zachary D Goodman, BioMed Central

Press Mentions

Major Histocompatibility Complex Class I‐Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver DiseaseSeptember 30th, 2020
The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanMarch 2nd, 2020
New Long-Term Data Presented at AASLD Show Reduction in Liver Fibrosis and Cirrhosis in a Cohort of Patients with Lysosomal Acid Lipase Deficiency (LAL-D) Treated with Kanuma® (Sebelipase Alfa)November 11th, 2016